abstract |
The invention belongs to the field of pharmaceutical preparations, in particular to a compound sustained-release preparation containing pitavastatin calcium and ezetimibe. The tablet contains meglumine and chitosan, which can not only improve the stability of pitavastatin calcium, but also enhance the solubility of ezetimibe, with high content of active ingredients and high patient compliance. |